The fastest-growing and largest of the 26 sized Medical Devices markets in Europe, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Anesthesia Monitoring Devices | $502 Mn | $1.5 Bn | 11.2% | 94 |
| 2 | Aesthetic Lasers and Energy Devices | $308 Mn | $862 Mn | 10.8% | 33 |
| 3 | Insulin Patch Pumps | $169 Mn | $469 Mn | 10.7% | 5 |
| 4 | Dental Caries Detectors | $70 Mn | $192 Mn | 10.5% | 9 |
| 5 | Anesthesia & Respiratory Devices | $5.5 Bn | $12 Bn | 8.2% | 161 |
| 6 | Air Ambulance Life Support Solutions | $849 Mn | $1.8 Bn | 7.8% | 9 |
| 7 | Anti-Snoring Devices | $238 Mn | $491 Mn | 7.5% | 46 |
| 8 | Advanced Bipolar Direct Energy Devices | $589 Mn | $1.2 Bn | 7.4% | 142 |
| 9 | Acute Care Needleless Connectors | $93 Mn | $171 Mn | 6.2% | 1 |
| 10 | Disposable Surgical Devices | $1.7 Bn | $3.1 Bn | 6% | 3,006 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Diabetes Care Devices | $8.1 Bn | $12.7 Bn | 4.6% | 133 |
| 2 | Anesthesia & Respiratory Devices | $5.5 Bn | $12 Bn | 8.2% | 161 |
| 3 | Rehabilitation Equipments | $3.8 Bn | $6.1 Bn | 4.8% | 454 |
| 4 | Defibrillator | $3.4 Bn | $5.3 Bn | 4.6% | 157 |
| 5 | Insulin Delivery Devices | $3 Bn | $5 Bn | 5.2% | 63 |
| 6 | Angiography Devices | $2.4 Bn | $3.9 Bn | 5% | 390 |
| 7 | Dental Diagnostic and Surgical Equipments | $2.3 Bn | $4 Bn | 5.8% | 869 |
| 8 | Direct Energy Medical Devices | $2.1 Bn | $3 Bn | 3.7% | 346 |
| 9 | Disposable Surgical Devices | $1.7 Bn | $3.1 Bn | 6% | 3,006 |
| 10 | Audiology Devices | $1.5 Bn | $2.5 Bn | 5.1% | 94 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running, in UK, Germany, France, Italy, Spain, Russia.
Anesthesia Monitoring Devices grows fastest, at 11.2% a year from 2023 to 2033, ahead of Aesthetic Lasers and Energy Devices (10.8%).
Diabetes Care Devices is the largest, worth about $8.1 Bn in 2023 and $12.7 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.